6838 Formosa Pharmaceuticals: Announcement of Lifting Non-Compete Restrictions for Directors (Including Independent Directors)
NQ Score
44/100
N1 Content Completeness
10
AI Summary (NQ-processed)
Formosa Pharmaceuticals held its annual general meeting on May 25, 115, and approved the lifting of non-compete restrictions for Director Ma Hai-Yi and Independent Director Lo Li-Chu. Ma is permitted to serve as an independent director at Acepodia, and Lo is permitted to serve as an independent director at An-Bang Biotech. The motion passed with 98.72% approval.
AI Analysis
Frequently Asked Questions
- Q: When was the non-compete restriction lifted?
- A: It was approved at the shareholder meeting on May 25, 115.